☰
Gilead will gain exclusive access to all of the existing and upcoming compounds in Galapagos’ pipeline Foster City, California-headquartered drug maker Gilead Sciences is reportedly in talks to increase its share in Belgian-Dutch bio....
Microsoft, the tech giant, recently announced that its Azure Kinect Developer Kit, a $399 perception system for speech solutions & computer vision, will be available for shipping to pre-order customers in the U.S. and China, report sour....
Both parties have reportedly signed three joint study agreement under the framework CNOOC Limited, the largest crude oil and natural gas producer in China, recently announced that it has signed a Corporation Framework Agreement with Sinope....
Pulmatrix, Inc. has reportedly activated three sites in the United States for the phase-2 clinical trial of Pulmazole (PUR1900). It is an inhaled formulation consisting of itraconazole for treating allergic bronchopulmonary aspergillosis (A....
In a recent turn of events, Dermata Therapeutics, a development-stage biotechnology company, has announced positive outcomes from Phase I proof of concept clinical trial of DMT410 (which is a combination of DMT310 and botulinum toxin), for ....
The acquisition would facilitate ZipLine an entry into the gift card segment. The newly acquired assets further complement ZipLine’s existing customer payments as well as loyalty capabilities. ZipLine, a renowned rewards and mobi....
The tracking system would detect stolen mobile phones, even if the IMEI number is changed or the SIM card is removed. DoT (The Department of Telecommunications) recently announced the launch of a technology solution to enable detection of ....
OntarioMD, a company specializing in the selection, implementation and adoption of electronic medical records (EMR) and provincial digital health tools, recently announced that it will be adding 12 hospitals in north west Ontario to its pro....
AM-201 is an investigating drug being developed for the prevention of antipsychotic drug induced weight gain and somnolence. Auris Medical Ltd. – a biopharmaceutical company has reportedly completed the enrollment of its phase 1b pr....
Hemostemix Inc., a Canada-based biotechnology company recently announced that its CLI (critical limb ischemia) trial abstract has been accepted to be presented at the 41st Annual Meeting of Canadian Society for Vascular Surgery. For t....
